Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

23 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Mini-consolidations or intermediate-dose cytarabine for the post-remission therapy of AML patients over 60. A retrospective study from the DATAML and SAL registries.
Récher C, Dumas PY, Bérard E, Tavitian S, Leguay T, Galtier J, Alric C, Bidet A, Delabesse E, Rieu JB, Vial JP, Vergez F, Luquet I, Klein E, de Grande AC, Sarry A, Zukunft S, Platzbecker U, Müller-Tidow C, Baldus CD, Bornhäuser M, Serve H, Bertoli S, Pigneux A, Röllig C. Récher C, et al. Among authors: alric c. Am J Hematol. 2025 Jan;100(1):23-32. doi: 10.1002/ajh.27510. Epub 2024 Nov 18. Am J Hematol. 2025. PMID: 39555737 Free PMC article.
Intermediate-dose cytarabine or standard-dose cytarabine plus single-dose anthracycline as post-remission therapy in older patients with acute myeloid leukemia: impact on health care resource consumption and outcomes.
Galtier J, Alric C, Bérard E, Leguay T, Tavitian S, Bidet A, Delabesse E, Rieu JB, Vial JP, Vergez F, Lechevalier N, Luquet I, Klein E, de Grande AC, Sarry A, Pigneux A, Récher C, Bertoli S, Dumas PY. Galtier J, et al. Among authors: alric c. Blood Cancer J. 2021 Nov 13;11(11):180. doi: 10.1038/s41408-021-00551-y. Blood Cancer J. 2021. PMID: 34775463 Free PMC article. No abstract available.
Delivering HDAC over 3 or 5 days as consolidation in AML impacts health care resource consumption but not outcome.
Dumas PY, Bertoli S, Bérard E, Leguay T, Tavitian S, Galtier J, Alric C, Bidet A, Delabesse E, Rieu JB, Vial JP, Vergez F, Lechevalier N, Luquet I, Klein E, Sarry A, Rey H, de Grande AC, Despas F, Pigneux A, Récher C. Dumas PY, et al. Among authors: alric c. Blood Adv. 2020 Aug 25;4(16):3840-3849. doi: 10.1182/bloodadvances.2020002511. Blood Adv. 2020. PMID: 32790847 Free PMC article.
Interferon-free compared to interferon-based antiviral regimens as first-line therapy for B-cell lymphoproliferative disorders associated with hepatitis C virus infection.
Frigeni M, Besson C, Visco C, Fontaine H, Goldaniga M, Visentini M, Pulsoni A, Torres HA, Peveling-Oberhag J, Rossotti R, Zaja F, Rigacci L, Merli M, Dorival C, Alric C, Piazza F, Gentile M, Ferrari A, Pirisi M, Nassi L, Rattotti S, Frustaci A, Milella M, Cencini E, Defrancesco I, Ferretti VV, Bruno R, Hermine O, Arcaini L. Frigeni M, et al. Among authors: alric c. Leukemia. 2020 May;34(5):1462-1466. doi: 10.1038/s41375-019-0687-2. Epub 2019 Dec 13. Leukemia. 2020. PMID: 31836855 No abstract available.
IL13-Mediated Dectin-1 and Mannose Receptor Overexpression Promotes Macrophage Antitumor Activities through Recognition of Sialylated Tumor Cells.
Alaeddine M, Prat M, Poinsot V, Gouazé-Andersson V, Authier H, Meunier E, Lefèvre L, Alric C, Dardenne C, Bernad J, Alric L, Segui B, Balard P, Couderc F, Couderc B, Pipy B, Coste A. Alaeddine M, et al. Among authors: alric c. Cancer Immunol Res. 2019 Feb;7(2):321-334. doi: 10.1158/2326-6066.CIR-18-0213. Epub 2019 Jan 4. Cancer Immunol Res. 2019. PMID: 30610060
Targeting HER2-breast tumors with scFv-decorated bimodal nanoprobes.
Alric C, Hervé-Aubert K, Aubrey N, Melouk S, Lajoie L, Même W, Même S, Courbebaisse Y, Ignatova AA, Feofanov AV, Chourpa I, Allard-Vannier E. Alric C, et al. J Nanobiotechnology. 2018 Feb 21;16(1):18. doi: 10.1186/s12951-018-0341-6. J Nanobiotechnology. 2018. PMID: 29466990 Free PMC article.
The In Vivo Radiosensitizing Effect of Gold Nanoparticles Based MRI Contrast Agents.
Miladi I, Alric C, Dufort S, Mowat P, Dutour A, Mandon C, Laurent G, Bräuer-Krisch E, Herath N, Coll JL, Dutreix M, Lux F, Bazzi R, Billotey C, Janier M, Perriat P, Le Duc G, Roux S, Tillement O. Miladi I, et al. Among authors: alric c. Small. 2014 Feb 4. doi: 10.1002/smll.201302303. Online ahead of print. Small. 2014. PMID: 24677791
The in vivo radiosensitizing effect of gold nanoparticles based MRI contrast agents.
Miladi I, Alric C, Dufort S, Mowat P, Dutour A, Mandon C, Laurent G, Bräuer-Krisch E, Herath N, Coll JL, Dutreix M, Lux F, Bazzi R, Billotey C, Janier M, Perriat P, Le Duc G, Roux S, Tillement O. Miladi I, et al. Among authors: alric c. Small. 2014 Mar 26;10(6):1116-24. doi: 10.1002/smll.201470036. Small. 2014. PMID: 24659273
23 results